Census · Published 2026-10-17 · updated 2026-10-21 · recorded, not live

100% of answers named a brand. 1% named a store-brand product.

What a leading AI assistant tells a shopper about headache, pain and allergy medicine, one buyer scenario at a time. 6,000+ data points measured by the Supracited AI engine. The buyer scenarios are further down.

Supracited AI engine

Each dot is one recorded AI answer, circling the brand it named first, on the ring of its buyer scenario. Hollow moons are brands the answers named but never first.

Pain and headache · 100 answers

Seasonal allergies · 20 answers

Advil came first in 51% of pain and headache answers and Tylenol in 39%, though Tylenol was named in more of them.

Zyrtec came first in 60% of seasonal allergy answers and Allegra in 35%. Claritin was named in every one of them and never first.

Pain and headache: answers by the brand they named first, out of 100 (20 for each buyer scenario)
BrandHeadacheTension headacheBack painGeneric or brandCheapest pickNamed firstNamed at all
Advil8 of 2014 of 209 of 207 of 2013 of 2051%88%
Tylenol12 of 206 of 203 of 2013 of 205 of 2039%98%
Aleve0 of 200 of 208 of 200 of 201 of 209%55%
Only a store’s brand0 of 200 of 200 of 200 of 201 of 201%1%
Motrin0 of 200 of 200 of 200 of 200 of 200%62%
Excedrin0 of 200 of 200 of 200 of 200 of 200%37%
Bayer0 of 200 of 200 of 200 of 200 of 200%6%
Seasonal allergies: answers by the brand they named first, out of 20 (20 for each buyer scenario)
BrandSeasonal allergiesNamed firstNamed at all
Zyrtec12 of 2060%100%
Allegra7 of 2035%100%
Benadryl1 of 205%25%
Claritin0 of 200%100%
Flonase0 of 200%100%
Nasacort0 of 200%80%

  • 62%

    Pointed to a health professional

    A doctor, a pharmacist or another health professional.

  • 97%

    Store brands named as a shop or an example

    Read one mention at a time, never counted by keyword.

  • 98%

    Went to the five most-named brands

    In the 100 pain and headache answers.

Who answered: Assistant A, a leading AI assistant with web search on, 120 answers, recorded 2026-10-17 · Assistant B, with web search, 18 answers, counted on their own · other AI systems, answering from memory. Assistants are identified to clients in their reports. Brand names here are measurement results, not recommendations.

Every answer, by buyer scenario

Supracited AI engine

Each dot is one recorded AI answer, collected by the Supracited AI engine: 20 for each buyer scenario, 120 in all. Pick a brand to see which answers named it.
Brand
  1. Headache100%80%80%35%65%
  2. Tension headache100%80%75%75%95%
  3. Back pain100%95%80%95%0%
  4. Generic or brand100%100%70%60%0%
  5. Cheapest pick90%85%5%10%25%
  6. Seasonal allergies0%0%0%0%0%

Tylenol

98%

And 0% of the 20 seasonal allergy answers.

Advil

88%

And 0% of the 20 seasonal allergy answers.

Motrin

62%

And 0% of the 20 seasonal allergy answers.

Aleve

55%

And 0% of the 20 seasonal allergy answers.

Excedrin

37%

And 0% of the 20 seasonal allergy answers.

Tylenol: named in 100% of answers on four buyer scenarios, against 0% on seasonal allergies.

Advil: named in 100% of answers on generic or brand, against 0% on seasonal allergies.

Motrin: named in 80% of answers on headache and back pain, against 0% on seasonal allergies.

Aleve: named in 95% of answers on back pain, against 0% on seasonal allergies.

Excedrin: named in 95% of answers on tension headache, against 0% on three buyer scenarios.

Each card shows the brands an answer named, in the order it named them. We quote only sentences we have checked as plain fact, such as what a brand is or where it is sold, and none of these answers has one.

Answers naming each brand, by buyer scenario, out of 20 each
Buyer scenarioTylenolAdvilMotrinAleveExcedrin
Pain and headache
Headache100%80%80%35%65%
Tension headache100%80%75%75%95%
Back pain100%95%80%95%0%
Generic or brand100%100%70%60%0%
Cheapest pick90%85%5%10%25%
Seasonal allergies
Seasonal allergies0%0%0%0%0%

The names the answers gave

Each bar is the share of recorded answers that named it. Hover or tap a name for its count, its range and what the count means. Pick an assistant to compare; counts are never added across assistants. Pick a group of buyer scenarios to see its counts alone; the groups are never blended.

Assistant
Buyer scenarios

Pain and headache only: 100 of 120 recorded answers, five buyer scenarios each asked 20 times.

  1. Named in 100% of recorded answers on pain and headache (100 of 100). All six buyer scenarios: 100 of 120 (83%), range 50 to 100%. Counts mentions, including cautions; not recommendations.
  2. Named in 100% of recorded answers on pain and headache (100 of 100). All six buyer scenarios: 100 of 120 (83%), range 50 to 100%. Counts mentions, including cautions; not recommendations.
  3. Named in 98% of recorded answers on pain and headache (98 of 100). All six buyer scenarios: 98 of 120 (82%), range 48 to 100%. Counts mentions, including cautions; not recommendations.
  4. Named in 88% of recorded answers on pain and headache (88 of 100). All six buyer scenarios: 88 of 120 (73%), range 43 to 94%. Counts mentions, including cautions; not recommendations.
  5. Named in 68% of recorded answers on pain and headache (68 of 100). All six buyer scenarios: 68 of 120 (57%), range 24 to 87%. Counts mentions, including cautions; not recommendations.
  6. Named in 63% of recorded answers on pain and headache (63 of 100). All six buyer scenarios: 63 of 120 (53%), range 23 to 82%. Counts mentions, including cautions; not recommendations.
  7. Named in 62% of recorded answers on pain and headache (62 of 100). All six buyer scenarios: 62 of 120 (52%), range 23 to 78%. Counts mentions, including cautions; not recommendations.
  8. Named in 55% of recorded answers on pain and headache (55 of 100). All six buyer scenarios: 55 of 120 (46%), range 18 to 73%. Counts mentions, including cautions; not recommendations.
  9. Named in 37% of recorded answers on pain and headache (37 of 100). All six buyer scenarios: 37 of 120 (31%), range 3 to 63%. Counts mentions, including cautions; not recommendations.
  10. Named in 15% of recorded answers on pain and headache (15 of 100). All six buyer scenarios: 15 of 120 (13%), range 0 to 29%. Counts mentions, including cautions; not recommendations.
Show 4 more names
  1. Named in 11% of recorded answers on pain and headache (11 of 100). All six buyer scenarios: 11 of 120 (9%), range 0 to 26%. Counts mentions, including cautions; not recommendations.
  2. Named in 9% of recorded answers on pain and headache (9 of 100). All six buyer scenarios: 9 of 120 (8%), range 0 to 18%. Counts mentions, including cautions; not recommendations.
  3. Named in 6% of recorded answers on pain and headache (6 of 100). All six buyer scenarios: 6 of 120 (5%), range 0 to 13%. Counts mentions, including cautions; not recommendations.
  4. Named in 1% of recorded answers on pain and headache (1 of 100). All six buyer scenarios: 4 of 120 (3%), range 0 to 10%. Counts mentions, including cautions; not recommendations.
  • Share of these answers that named it

Ranges are published for all six buyer scenarios together; this view shows counts only. Named in none of these 100 answers: Zyrtec, Cetirizine, Allegra, Fexofenadine, Claritin, Loratadine, Flonase, Nasacort, Fluticasone and Benadryl.

Seasonal allergies only: 20 of 120 recorded answers, one buyer scenario each asked 20 times.

  1. Named in 100% of recorded answers on seasonal allergies (20 of 20). All six buyer scenarios: 20 of 120 (17%), range 0 to 50%. Counts mentions, including cautions; not recommendations.
  2. Named in 100% of recorded answers on seasonal allergies (20 of 20). All six buyer scenarios: 20 of 120 (17%), range 0 to 50%. Counts mentions, including cautions; not recommendations.
  3. Named in 100% of recorded answers on seasonal allergies (20 of 20). All six buyer scenarios: 20 of 120 (17%), range 0 to 50%. Counts mentions, including cautions; not recommendations.
  4. Named in 100% of recorded answers on seasonal allergies (20 of 20). All six buyer scenarios: 20 of 120 (17%), range 0 to 50%. Counts mentions, including cautions; not recommendations.
  5. Named in 100% of recorded answers on seasonal allergies (20 of 20). All six buyer scenarios: 20 of 120 (17%), range 0 to 50%. Counts mentions, including cautions; not recommendations.
  6. Named in 100% of recorded answers on seasonal allergies (20 of 20). All six buyer scenarios: 20 of 120 (17%), range 0 to 50%. Counts mentions, including cautions; not recommendations.
  7. Named in 100% of recorded answers on seasonal allergies (20 of 20). All six buyer scenarios: 20 of 120 (17%), range 0 to 50%. Counts mentions, including cautions; not recommendations.
  8. Named in 80% of recorded answers on seasonal allergies (16 of 20). All six buyer scenarios: 16 of 120 (13%), range 0 to 41%. Counts mentions, including cautions; not recommendations.
  9. Named in 70% of recorded answers on seasonal allergies (14 of 20). All six buyer scenarios: 14 of 120 (12%), range 0 to 37%. Counts mentions, including cautions; not recommendations.
  10. Named in 25% of recorded answers on seasonal allergies (5 of 20). All six buyer scenarios: 5 of 120 (4%), range 0 to 14%. Counts mentions, including cautions; not recommendations.
  11. Named in 15% of recorded answers on seasonal allergies (3 of 20). All six buyer scenarios: 4 of 120 (3%), range 0 to 10%. Counts mentions, including cautions; not recommendations.
  • Share of these answers that named it

Ranges are published for all six buyer scenarios together; this view shows counts only. Named in none of these 20 answers: Ibuprofen, Acetaminophen, Tylenol, Advil, Naproxen, Aspirin, Motrin, Aleve, Excedrin, CVS Health, Equate, Walgreens and Bayer.

120 recorded answers, six buyer scenarios each asked 20 times, collected 2026-10-17.

  1. Named in 83% of recorded answers (100 of 120). Range if the census ran again: 50 to 100%. Effective n: 6 of 120 answers (ICC 1.00, design effect 20.0). In the first three names: 96 of 120. Counts mentions, including cautions; not recommendations.
  2. Named in 83% of recorded answers (100 of 120). Range if the census ran again: 50 to 100%. Effective n: 6 of 120 answers (ICC 1.00, design effect 20.0). In the first three names: 59 of 120. Counts mentions, including cautions; not recommendations.
  3. Named in 82% of recorded answers (98 of 120). Range if the census ran again: 48 to 100%. Effective n: 7 of 120 answers (ICC 0.91, design effect 18.3). In the first three names: 26 of 120. Counts mentions, including cautions; not recommendations.
  4. Named in 73% of recorded answers (88 of 120). Range if the census ran again: 43 to 94%. Effective n: 10 of 120 answers (ICC 0.60, design effect 12.4). In the first three names: 43 of 120. Counts mentions, including cautions; not recommendations.
  5. Named in 57% of recorded answers (68 of 120). Range if the census ran again: 24 to 87%. Effective n: 9 of 120 answers (ICC 0.63, design effect 13.0). In the first three names: 28 of 120. Counts mentions, including cautions; not recommendations.
  6. Named in 53% of recorded answers (63 of 120). Range if the census ran again: 23 to 82%. Effective n: 10 of 120 answers (ICC 0.60, design effect 12.4). In the first three names: 4 of 120. Counts mentions, including cautions; not recommendations.
  7. Named in 52% of recorded answers (62 of 120). Range if the census ran again: 23 to 78%. Effective n: 11 of 120 answers (ICC 0.51, design effect 10.7). In the first three names: 26 of 120. Counts mentions, including cautions; not recommendations.
  8. Named in 46% of recorded answers (55 of 120). Range if the census ran again: 18 to 73%. Effective n: 12 of 120 answers (ICC 0.49, design effect 10.3). In the first three names: 7 of 120. Counts mentions, including cautions; not recommendations.
  9. Named in 31% of recorded answers (37 of 120). Range if the census ran again: 3 to 63%. Effective n: 9 of 120 answers (ICC 0.66, design effect 13.6). In the first three names: 0 of 120. Counts mentions, including cautions; not recommendations.
  10. Named in 17% of recorded answers (20 of 120). Range if the census ran again: 0 to 50%. Effective n: 6 of 120 answers (ICC 1.00, design effect 20.0). In the first three names: 18 of 120. Counts mentions, including cautions; not recommendations.
  11. Named in 17% of recorded answers (20 of 120). Range if the census ran again: 0 to 50%. Effective n: 6 of 120 answers (ICC 1.00, design effect 20.0). In the first three names: 13 of 120. Counts mentions, including cautions; not recommendations.
  12. Named in 17% of recorded answers (20 of 120). Range if the census ran again: 0 to 50%. Effective n: 6 of 120 answers (ICC 1.00, design effect 20.0). In the first three names: 11 of 120. Counts mentions, including cautions; not recommendations.
  13. Named in 17% of recorded answers (20 of 120). Range if the census ran again: 0 to 50%. Effective n: 6 of 120 answers (ICC 1.00, design effect 20.0). In the first three names: 14 of 120. Counts mentions, including cautions; not recommendations.
  14. Named in 17% of recorded answers (20 of 120). Range if the census ran again: 0 to 50%. Effective n: 6 of 120 answers (ICC 1.00, design effect 20.0). In the first three names: 1 of 120. Counts mentions, including cautions; not recommendations.
  15. Named in 17% of recorded answers (20 of 120). Range if the census ran again: 0 to 50%. Effective n: 6 of 120 answers (ICC 1.00, design effect 20.0). In the first three names: 2 of 120. Counts mentions, including cautions; not recommendations.
  16. Named in 17% of recorded answers (20 of 120). Range if the census ran again: 0 to 50%. Effective n: 6 of 120 answers (ICC 1.00, design effect 20.0). In the first three names: 0 of 120. Counts mentions, including cautions; not recommendations.
Show 8 more names
  1. Named in 13% of recorded answers (16 of 120). Range if the census ran again: 0 to 41%. Effective n: 8 of 120 answers (ICC 0.79, design effect 16.0). In the first three names: 0 of 120. Counts mentions, including cautions; not recommendations.
  2. Named in 13% of recorded answers (15 of 120). Range if the census ran again: 0 to 29%. Effective n: 18 of 120 answers (ICC 0.31, design effect 6.9). In the first three names: 4 of 120. Counts mentions, including cautions; not recommendations.
  3. Named in 12% of recorded answers (14 of 120). Range if the census ran again: 0 to 37%. Effective n: 9 of 120 answers (ICC 0.68, design effect 14.0). In the first three names: 0 of 120. Counts mentions, including cautions; not recommendations.
  4. Named in 9% of recorded answers (11 of 120). Range if the census ran again: 0 to 26%. Effective n: 16 of 120 answers (ICC 0.33, design effect 7.3). In the first three names: 6 of 120. Counts mentions, including cautions; not recommendations.
  5. Named in 8% of recorded answers (9 of 120). Range if the census ran again: 0 to 18%. Effective n: 31 of 120 answers (ICC 0.15, design effect 3.8). In the first three names: 1 of 120. Counts mentions, including cautions; not recommendations.
  6. Named in 5% of recorded answers (6 of 120). Range if the census ran again: 0 to 13%. Effective n: 48 of 120 answers (ICC 0.08, design effect 2.5). In the first three names: 0 of 120. Counts mentions, including cautions; not recommendations.
  7. Named in 4% of recorded answers (5 of 120). Range if the census ran again: 0 to 14%. Effective n: 24 of 120 answers (ICC 0.21, design effect 5.0). In the first three names: 1 of 120. Counts mentions, including cautions; not recommendations.
  8. Named in 3% of recorded answers (4 of 120). Range if the census ran again: 0 to 10%. Effective n: 54 of 120 answers (ICC 0.06, design effect 2.2). In the first three names: 0 of 120. Counts mentions, including cautions; not recommendations.
  • Share of answers that named it
  • Range if the census ran again

Pain and headache only: 15 of 18 recorded answers, five buyer scenarios each asked 3 times.

  1. Named in 87% of recorded answers on pain and headache (13 of 15). All six buyer scenarios: 13 of 18 (72%), range 33 to 100%. Counts mentions, including cautions; not recommendations.
  2. Named in 87% of recorded answers on pain and headache (13 of 15). All six buyer scenarios: 13 of 18 (72%), range 33 to 100%. Counts mentions, including cautions; not recommendations.
  3. Named in 73% of recorded answers on pain and headache (11 of 15). All six buyer scenarios: 11 of 18 (61%), range 28 to 89%. Counts mentions, including cautions; not recommendations.
  4. Named in 53% of recorded answers on pain and headache (8 of 15). All six buyer scenarios: 8 of 18 (44%), range 11 to 78%. Counts mentions, including cautions; not recommendations.
  5. Named in 47% of recorded answers on pain and headache (7 of 15). All six buyer scenarios: 7 of 18 (39%), range 6 to 72%. Counts mentions, including cautions; not recommendations.
  6. Named in 27% of recorded answers on pain and headache (4 of 15). All six buyer scenarios: 4 of 18 (22%), range 0 to 56%. Counts mentions, including cautions; not recommendations.
  7. Named in 7% of recorded answers on pain and headache (1 of 15). All six buyer scenarios: 1 of 18 (6%), range 0 to 22%. Counts mentions, including cautions; not recommendations.
  8. Named in 7% of recorded answers on pain and headache (1 of 15). All six buyer scenarios: 1 of 18 (6%), range 0 to 22%. Counts mentions, including cautions; not recommendations.
  • Share of these answers that named it

Ranges are published for all six buyer scenarios together; this view shows counts only. Named in none of these 15 answers: Fluticasone, Loratadine, Fexofenadine, Cetirizine, Flonase, Nasacort, Claritin, Allegra, Zyrtec and Diphenhydramine.

Seasonal allergies only: 3 of 18 recorded answers, one buyer scenario each asked 3 times.

  1. Named in 3 of 3 recorded answers on seasonal allergies. All six buyer scenarios: 3 of 18 (17%), range 0 to 50%. Counts mentions, including cautions; not recommendations.
  2. Named in 3 of 3 recorded answers on seasonal allergies. All six buyer scenarios: 3 of 18 (17%), range 0 to 50%. Counts mentions, including cautions; not recommendations.
  3. Named in 3 of 3 recorded answers on seasonal allergies. All six buyer scenarios: 3 of 18 (17%), range 0 to 50%. Counts mentions, including cautions; not recommendations.
  4. Named in 3 of 3 recorded answers on seasonal allergies. All six buyer scenarios: 3 of 18 (17%), range 0 to 50%. Counts mentions, including cautions; not recommendations.
  5. Named in 2 of 3 recorded answers on seasonal allergies. All six buyer scenarios: 2 of 18 (11%), range 0 to 39%. Counts mentions, including cautions; not recommendations.
  6. Named in 2 of 3 recorded answers on seasonal allergies. All six buyer scenarios: 2 of 18 (11%), range 0 to 39%. Counts mentions, including cautions; not recommendations.
  7. Named in 2 of 3 recorded answers on seasonal allergies. All six buyer scenarios: 2 of 18 (11%), range 0 to 39%. Counts mentions, including cautions; not recommendations.
  8. Named in 2 of 3 recorded answers on seasonal allergies. All six buyer scenarios: 2 of 18 (11%), range 0 to 39%. Counts mentions, including cautions; not recommendations.
  9. Named in 2 of 3 recorded answers on seasonal allergies. All six buyer scenarios: 2 of 18 (11%), range 0 to 39%. Counts mentions, including cautions; not recommendations.
  10. Named in 1 of 3 recorded answers on seasonal allergies. All six buyer scenarios: 1 of 18 (6%), range 0 to 22%. Counts mentions, including cautions; not recommendations.
  • Share of these answers that named it

Ranges are published for all six buyer scenarios together; this view shows counts only. Named in none of these 3 answers: Ibuprofen, Acetaminophen, Tylenol, Advil, Motrin, Naproxen, Aspirin and Aleve.

18 recorded answers, six buyer scenarios each asked 3 times, collected 2026-10-17.

  1. Named in 72% of recorded answers (13 of 18). Range if the census ran again: 33 to 100%. Effective n: 7 of 18 answers (ICC 0.76, design effect 2.5). In the first three names: 13 of 18. Counts mentions, including cautions; not recommendations.
  2. Named in 72% of recorded answers (13 of 18). Range if the census ran again: 33 to 100%. Effective n: 7 of 18 answers (ICC 0.76, design effect 2.5). In the first three names: 9 of 18. Counts mentions, including cautions; not recommendations.
  3. Named in 61% of recorded answers (11 of 18). Range if the census ran again: 28 to 89%. Effective n: 10 of 18 answers (ICC 0.37, design effect 1.7). In the first three names: 7 of 18. Counts mentions, including cautions; not recommendations.
  4. Named in 44% of recorded answers (8 of 18). Range if the census ran again: 11 to 78%. Effective n: 10 of 18 answers (ICC 0.39, design effect 1.8). In the first three names: 5 of 18. Counts mentions, including cautions; not recommendations.
  5. Named in 39% of recorded answers (7 of 18). Range if the census ran again: 6 to 72%. Effective n: 8 of 18 answers (ICC 0.59, design effect 2.2). In the first three names: 4 of 18. Counts mentions, including cautions; not recommendations.
  6. Named in 22% of recorded answers (4 of 18). Range if the census ran again: 0 to 56%. Effective n: 7 of 18 answers (ICC 0.72, design effect 2.4). In the first three names: 1 of 18. Counts mentions, including cautions; not recommendations.
  7. Named in 17% of recorded answers (3 of 18). Range if the census ran again: 0 to 50%. Effective n: 6 of 18 answers (ICC 1.00, design effect 3.0). In the first three names: 2 of 18. Counts mentions, including cautions; not recommendations.
  8. Named in 17% of recorded answers (3 of 18). Range if the census ran again: 0 to 50%. Effective n: 6 of 18 answers (ICC 1.00, design effect 3.0). In the first three names: 1 of 18. Counts mentions, including cautions; not recommendations.
  9. Named in 17% of recorded answers (3 of 18). Range if the census ran again: 0 to 50%. Effective n: 6 of 18 answers (ICC 1.00, design effect 3.0). In the first three names: 1 of 18. Counts mentions, including cautions; not recommendations.
  10. Named in 17% of recorded answers (3 of 18). Range if the census ran again: 0 to 50%. Effective n: 6 of 18 answers (ICC 1.00, design effect 3.0). In the first three names: 1 of 18. Counts mentions, including cautions; not recommendations.
Show 8 more names
  1. Named in 11% of recorded answers (2 of 18). Range if the census ran again: 0 to 39%. Effective n: 9 of 18 answers (ICC 0.50, design effect 2.0). In the first three names: 2 of 18. Counts mentions, including cautions; not recommendations.
  2. Named in 11% of recorded answers (2 of 18). Range if the census ran again: 0 to 39%. Effective n: 9 of 18 answers (ICC 0.50, design effect 2.0). In the first three names: 2 of 18. Counts mentions, including cautions; not recommendations.
  3. Named in 11% of recorded answers (2 of 18). Range if the census ran again: 0 to 39%. Effective n: 9 of 18 answers (ICC 0.50, design effect 2.0). In the first three names: 0 of 18. Counts mentions, including cautions; not recommendations.
  4. Named in 11% of recorded answers (2 of 18). Range if the census ran again: 0 to 39%. Effective n: 9 of 18 answers (ICC 0.50, design effect 2.0). In the first three names: 0 of 18. Counts mentions, including cautions; not recommendations.
  5. Named in 11% of recorded answers (2 of 18). Range if the census ran again: 0 to 39%. Effective n: 9 of 18 answers (ICC 0.50, design effect 2.0). In the first three names: 0 of 18. Counts mentions, including cautions; not recommendations.
  6. Named in 6% of recorded answers (1 of 18). Range if the census ran again: 0 to 22%. Effective n: 18 of 18 answers (ICC 0.00, design effect 1.0). In the first three names: 0 of 18. Counts mentions, including cautions; not recommendations.
  7. Named in 6% of recorded answers (1 of 18). Range if the census ran again: 0 to 22%. Effective n: 18 of 18 answers (ICC 0.00, design effect 1.0). In the first three names: 0 of 18. Counts mentions, including cautions; not recommendations.
  8. Named in 6% of recorded answers (1 of 18). Range if the census ran again: 0 to 22%. Effective n: 18 of 18 answers (ICC 0.00, design effect 1.0). In the first three names: 0 of 18. Counts mentions, including cautions; not recommendations.
  • Share of answers that named it
  • Range if the census ran again

Each assistant was asked through the Supracited AI engine, with web search on, rather than inside its own app, which may answer differently.

See the numbers as a tableevery name each assistant gave, with both ranges, position and top three

Each row leads with a cluster-bootstrap range, which allows for the same question being asked again; the narrower Wilson range beside it assumes every answer is an independent draw. The method page explains why the bootstrap leads.

Exploratory: 6 buyer scenarios. An industry framework (IAB, August 2026) treats a program with fewer than 50 buyer scenarios as exploratory rather than directional; read these ranges as a guide, not a precise estimate. Known limits.

ICC, the intraclass correlation, is how alike the answers to one buyer scenario are: 0 is no more alike than chance, 1 is the same answer every time. The design effect is how much that widens a range, and effective n is the answers divided by it, roughly what they are worth as separate draws.

Assistant A: 120 answers with web search

120 answers: 6 buyer scenarios, each asked 20 times, collected 2026-10-17. Asked through the Supracited AI engine, with web search on, rather than inside the assistant’s own app, which may answer differently.

Narrow screen: scroll the table sideways for more columns.

n=120 answers · 6 buyer scenarios, each asked 20 times · collected 2026-10-17
Name Kind Share of answers (bar: bootstrap range, tick: observed) Wilson range (assumes independent answers) ICC · design effect · effective n Average position when named (1 = first) In the first three names
IbuprofenIngredient

50 to 100% · 100 of 120

76 to 89%1.00 · 20.0 · 61.6696 of 120 (80%)
AcetaminophenIngredient

50 to 100% · 100 of 120

76 to 89%1.00 · 20.0 · 63.0859 of 120 (49%)
TylenolBrand

48 to 100% · 98 of 120

74 to 88%0.91 · 18.3 · 74.7126 of 120 (22%)
AdvilBrand

43 to 94% · 88 of 120

65 to 80%0.60 · 12.4 · 103.5243 of 120 (36%)
NaproxenIngredient

24 to 87% · 68 of 120

48 to 65%0.63 · 13.0 · 94.0928 of 120 (23%)
AspirinIngredient

23 to 82% · 63 of 120

44 to 61%0.60 · 12.4 · 105.974 of 120 (3%)
MotrinBrand

23 to 78% · 62 of 120

43 to 60%0.51 · 10.7 · 114.4226 of 120 (22%)
AleveBrand

18 to 73% · 55 of 120

37 to 55%0.49 · 10.3 · 125.537 of 120 (6%)
ExcedrinBrand

3 to 63% · 37 of 120

23 to 40%0.66 · 13.6 · 97.510 of 120 (0%)
ZyrtecBrand

0 to 50% · 20 of 120

11 to 24%1.00 · 20.0 · 62.3018 of 120 (15%)
CetirizineIngredient

0 to 50% · 20 of 120

11 to 24%1.00 · 20.0 · 62.4013 of 120 (11%)
AllegraBrand

0 to 50% · 20 of 120

11 to 24%1.00 · 20.0 · 62.9511 of 120 (9%)
FexofenadineIngredient

0 to 50% · 20 of 120

11 to 24%1.00 · 20.0 · 63.0514 of 120 (12%)
ClaritinBrand

0 to 50% · 20 of 120

11 to 24%1.00 · 20.0 · 65.251 of 120 (1%)
LoratadineIngredient

0 to 50% · 20 of 120

11 to 24%1.00 · 20.0 · 65.352 of 120 (2%)
FlonaseBrand

0 to 50% · 20 of 120

11 to 24%1.00 · 20.0 · 67.400 of 120 (0%)
NasacortBrand

0 to 41% · 16 of 120

8 to 21%0.79 · 16.0 · 88.690 of 120 (0%)
CVS HealthStore brand

0 to 29% · 15 of 120

8 to 20%0.31 · 6.9 · 185.274 of 120 (3%)
FluticasoneIngredient

0 to 37% · 14 of 120

7 to 19%0.68 · 14.0 · 97.500 of 120 (0%)
EquateStore brand

0 to 26% · 11 of 120

5 to 16%0.33 · 7.3 · 164.186 of 120 (5%)
WalgreensStore brand

0 to 18% · 9 of 120

4 to 14%0.15 · 3.8 · 317.001 of 120 (1%)
BayerBrand

0 to 13% · 6 of 120

2 to 11%0.08 · 2.5 · 487.500 of 120 (0%)
BenadrylBrand

0 to 14% · 5 of 120

2 to 9%0.21 · 5.0 · 248.601 of 120 (1%)
DiphenhydramineIngredient

0 to 10% · 4 of 120

1 to 8%0.06 · 2.2 · 5410.500 of 120 (0%)
Kirkland SignatureStore brand

0% · 0 of 120

0 to 3%Not namedNot named0 of 120 (0%)
up & upStore brand

0% · 0 of 120

0 to 3%Not namedNot named0 of 120 (0%)
GoodSenseStore brand

0% · 0 of 120

0 to 3%Not namedNot named0 of 120 (0%)

Store brands, hand-coded one mention at a time: CVS Health 15 of 15 mentions a qualifier; Equate 14 of 15 mentions a qualifier and 1 a product; Walgreens 9 of 9 mentions a qualifier. The census counts Kirkland Signature by its full name only; “Kirkland” on its own appears in several answers, each time as one example in a list of store brands, never as a product.

Assistant B: 18 answers with web search, counted on their own

18 answers: 6 buyer scenarios, each asked 3 times, collected 2026-10-17. Asked through the Supracited AI engine, with web search on, rather than inside the assistant’s own app, which may answer differently.

Narrow screen: scroll the table sideways for more columns.

n=18 answers · 6 buyer scenarios, each asked 3 times · collected 2026-10-17
Name Kind Share of answers (bar: bootstrap range, tick: observed) Wilson range (assumes independent answers) ICC · design effect · effective n Average position when named (1 = first) In the first three names
IbuprofenIngredient

33 to 100% · 13 of 18

49 to 88%0.76 · 2.5 · 71.4613 of 18 (72%)
AcetaminophenIngredient

33 to 100% · 13 of 18

49 to 88%0.76 · 2.5 · 72.629 of 18 (50%)
TylenolBrand

28 to 89% · 11 of 18

39 to 80%0.37 · 1.7 · 103.457 of 18 (39%)
AdvilBrand

11 to 78% · 8 of 18

25 to 66%0.39 · 1.8 · 102.755 of 18 (28%)
MotrinBrand

6 to 72% · 7 of 18

20 to 61%0.59 · 2.2 · 83.864 of 18 (22%)
NaproxenIngredient

0 to 56% · 4 of 18

9 to 45%0.72 · 2.4 · 73.751 of 18 (6%)
FluticasoneIngredient

0 to 50% · 3 of 18

6 to 39%1.00 · 3.0 · 62.002 of 18 (11%)
LoratadineIngredient

0 to 50% · 3 of 18

6 to 39%1.00 · 3.0 · 64.001 of 18 (6%)
FexofenadineIngredient

0 to 50% · 3 of 18

6 to 39%1.00 · 3.0 · 64.331 of 18 (6%)
CetirizineIngredient

0 to 50% · 3 of 18

6 to 39%1.00 · 3.0 · 65.671 of 18 (6%)
FlonaseBrand

0 to 39% · 2 of 18

3 to 33%0.50 · 2.0 · 92.002 of 18 (11%)
NasacortBrand

0 to 39% · 2 of 18

3 to 33%0.50 · 2.0 · 93.002 of 18 (11%)
ClaritinBrand

0 to 39% · 2 of 18

3 to 33%0.50 · 2.0 · 96.000 of 18 (0%)
AllegraBrand

0 to 39% · 2 of 18

3 to 33%0.50 · 2.0 · 96.000 of 18 (0%)
ZyrtecBrand

0 to 39% · 2 of 18

3 to 33%0.50 · 2.0 · 99.000 of 18 (0%)
AspirinIngredient

0 to 22% · 1 of 18

1 to 26%0.00 · 1.0 · 185.000 of 18 (0%)
DiphenhydramineIngredient

0 to 22% · 1 of 18

1 to 26%0.00 · 1.0 · 185.000 of 18 (0%)
AleveBrand

0 to 22% · 1 of 18

1 to 26%0.00 · 1.0 · 186.000 of 18 (0%)
EquateStore brand

0% · 0 of 18

0 to 18%Not namedNot named0 of 18 (0%)
Kirkland SignatureStore brand

0% · 0 of 18

0 to 18%Not namedNot named0 of 18 (0%)
CVS HealthStore brand

0% · 0 of 18

0 to 18%Not namedNot named0 of 18 (0%)
WalgreensStore brand

0% · 0 of 18

0 to 18%Not namedNot named0 of 18 (0%)
up & upStore brand

0% · 0 of 18

0 to 18%Not namedNot named0 of 18 (0%)
GoodSenseStore brand

0% · 0 of 18

0 to 18%Not namedNot named0 of 18 (0%)

No store brand was named in these 18 answers.

Other AI models, answering from memory

Answering from memory means no web search: this shows what the models recall, not what a product built on them shows a buyer.

The census’s six buyer scenarios, asked with no web search. Collected 2026-10-18.

From memory, the models treat the big pain brands as near peers. With search, the answers tilt toward Tylenol and Advil.

Answering from memory

Other AI models together, all six buyer scenarios, 66 answers

  1. Named in 65% of recorded answers (43 of 66). Range if the buyer scenarios were asked again: 36 to 86%. Counts mentions, including cautions; not recommendations.
  2. Named in 67% of recorded answers (44 of 66). Range if the buyer scenarios were asked again: 36 to 89%. Counts mentions, including cautions; not recommendations.
  3. Named in 64% of recorded answers (42 of 66). Range if the buyer scenarios were asked again: 35 to 85%. Counts mentions, including cautions; not recommendations.
  4. Named in 50% of recorded answers (33 of 66). Range if the buyer scenarios were asked again: 20 to 77%. Counts mentions, including cautions; not recommendations.

Assistant A, searching the web

All six buyer scenarios, 120 answers

  1. Named in 82% of recorded answers (98 of 120). Range if the buyer scenarios were asked again: 48 to 100%. Counts mentions, including cautions; not recommendations.
  2. Named in 73% of recorded answers (88 of 120). Range if the buyer scenarios were asked again: 43 to 94%. Counts mentions, including cautions; not recommendations.
  3. Named in 52% of recorded answers (62 of 120). Range if the buyer scenarios were asked again: 23 to 78%. Counts mentions, including cautions; not recommendations.
  4. Named in 46% of recorded answers (55 of 120). Range if the buyer scenarios were asked again: 18 to 73%. Counts mentions, including cautions; not recommendations.

Assistant B, searching the web

All six buyer scenarios, 18 answers

  1. Named in 61% of recorded answers (11 of 18). Range if the buyer scenarios were asked again: 28 to 89%. Counts mentions, including cautions; not recommendations.
  2. Named in 44% of recorded answers (8 of 18). Range if the buyer scenarios were asked again: 11 to 78%. Counts mentions, including cautions; not recommendations.
  3. Named in 39% of recorded answers (7 of 18). Range if the buyer scenarios were asked again: 6 to 72%. Counts mentions, including cautions; not recommendations.
  4. Named in 6% of recorded answers (1 of 18). Range if the buyer scenarios were asked again: 0 to 22%. Counts mentions, including cautions; not recommendations.

The same six buyer scenarios in all three. Each bar is the share of answers that named the brand, with the range we would expect if the buyer scenarios were asked again; with six buyer scenarios the ranges are wide. Hover or tap a brand for its count. Answers that came back empty are left out of every count.

The sites the answers were built from

The twelve domains cited most, ranked by how many answers linked them. None is a maker’s or a retailer’s own site, so that is where a fix list starts. Hover or tap a site for what it is.

Assistant A, with web search: the twelve sites cited most, out of 120 recorded answers.

  1. Cited in 29% of recorded answers (35 of 120). What it is: AI doctor and telehealth service. Cited in: linked at least once in the answer.
  2. Cited in 28% of recorded answers (34 of 120). What it is: Drug price site. Cited in: linked at least once in the answer.
  3. Cited in 15% of recorded answers (18 of 120). What it is: Health information site, no named owner. Cited in: linked at least once in the answer.
  4. Cited in 12% of recorded answers (14 of 120). What it is: Consumer group, price comparison. Cited in: linked at least once in the answer.
  5. Cited in 11% of recorded answers (13 of 120). What it is: US drug regulator. Cited in: linked at least once in the answer.
  6. Cited in 11% of recorded answers (13 of 120). What it is: Academic medical center. Cited in: linked at least once in the answer.
  7. Cited in 10% of recorded answers (12 of 120). What it is: Medical school publisher. Cited in: linked at least once in the answer.
  8. Cited in 9% of recorded answers (11 of 120). What it is: Ear, nose and throat practice in Georgia. Cited in: linked at least once in the answer.
  9. Cited in 8% of recorded answers (10 of 120). What it is: Integrative care program. Cited in: linked at least once in the answer.
  10. Cited in 8% of recorded answers (10 of 120). What it is: Primary care membership. Cited in: linked at least once in the answer.
  11. Cited in 8% of recorded answers (9 of 120). What it is: Hospital system. Cited in: linked at least once in the answer.
  12. Cited in 6% of recorded answers (7 of 120). What it is: US National Library of Medicine. Cited in: linked at least once in the answer.
  • Share of answers that linked the site at least once

Assistant B, with web search: the six sites cited most, out of 18 recorded answers.

  1. Cited in 67% of recorded answers (12 of 18). What it is: US drug regulator. Cited in: linked at least once in the answer.
  2. Cited in 50% of recorded answers (9 of 18). What it is: US National Library of Medicine. Cited in: linked at least once in the answer.
  3. Cited in 22% of recorded answers (4 of 18). Cited site. Cited in: linked at least once in the answer.
  4. Cited in 11% of recorded answers (2 of 18). Cited site. Cited in: linked at least once in the answer.
  5. Cited in 11% of recorded answers (2 of 18). What it is: Academic medical center. Cited in: linked at least once in the answer.
  6. Cited in 6% of recorded answers (1 of 18). Cited site. Cited in: linked at least once in the answer.
  • Share of answers that linked the site at least once

Retailers: None among the twelve most cited. walmart.com is cited too, mostly on the cheapest-medicine question, below the twelve.

Cited in: the number of the 120 answers that linked the domain at least once. Types checked on each site’s own homepage on 2026-10-17.

The buyer scenarios asked

Written the way a shopper types, naming no brand. How each one is run, counted and checked: the method page.

Hover, focus or tap a scenario to read the question as asked.

Correctionsevery change to this page, dated
  • 2026-10-21: the two assistants are labelled Assistant A and Assistant B instead of by name, and the one census outside consumer health is retired. No count changed.
  • 2026-10-21: the lane answering from memory now shows its answers together, without naming or counting the systems behind it. No count changed.
  • 2026-10-19: the page now opens with an orbit map of the brand each answer named first; the dots by buyer scenario moved one section down. No count changed.
  • 2026-10-19: the share of answers that pointed to a health professional counted three answers whose only such word sat in a source link or a link’s title; it now reads the answer’s own words only: 62% (74 of 120), was 64% (77 of 120). No brand count changed.
  • 2026-10-19: the page now opens with every recorded answer as a dot, by buyer scenario, and leads with shares; the annotated answer was retired, since recorded answers can now be read from the dots. No count changed.
  • 2026-10-19: the chart now opens on the five pain and headache buyer scenarios; all six together stay one click away. No count changed.
  • 2026-10-18: bars replaced the shelves and the tables as the first view; every table stays beneath its chart, and each count now leads with its share of the answers. No count or range changed.
  • 2026-10-18: every range on this page now comes from the one statistics code all our censuses share. Some 95% ranges moved by up to 2 points. No count changed.
  • 2026-10-18: added Assistant B (18 answers, counted on their own) and a lane of other AI systems answering from memory, with no web search. No count from Assistant A changed.
  • 2026-10-17: one tracked store label was removed from the full table for presentation; it was named in 0 of 120 answers, so no count or finding on this page changes.
  • 2026-10-17: moved from /census-otc to this address; the old address redirects here. No count changed.
  • 2026-10-17: first publication.

We measure and source. We do not write, edit or suggest any statement about what a product does; that stays as your label states it. Brand names in our censuses are measurement results, not recommendations.

How we count

Other censuses

Want your own brand on this shelf?

Start with three buyer scenarios. We send back which brands AI named, which sites it cited and one source worth a closer look.

Get a free Shelf Check